Literature DB >> 16026744

Neurological aspects of multiple myeloma and related disorders.

Angela Dispenzieri1, Robert A Kyle.   

Abstract

The spectrum of neurologic complications of multiple myeloma (MM) and related conditions is as diverse as the conditions themselves. Complications range from direct compression (radiculopathy, spinal cord compression, base-of-the-skull tumor) to the infiltrative (amyloid, peripheral neuropathies, and numb chin syndrome of myeloma), the metabolic (slowed mentation from hyperviscosity, hypercalcemia, or uremia), and to autoimmune or cytokine-mediated (peripheral neuropathy). The two most common presentations are the compressive radiculopathy one sees in multiple myeloma and the peripheral neuropathies associated with many of the other disorders. The authors will review the neurologic complications of MM, monoclonal gammopathy of undetermined significance (MGUS), Waldenström macroglobulinemia (WM), POEMS syndrome, amyloidosis, and cryoglobulinemia.

Entities:  

Mesh:

Year:  2005        PMID: 16026744     DOI: 10.1016/j.beha.2005.01.024

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  23 in total

1.  Schnitzler syndrome: an under-diagnosed clinical entity.

Authors:  Tania Jain; Chetan P Offord; Robert A Kyle; David Dingli
Journal:  Haematologica       Date:  2013-06-28       Impact factor: 9.941

Review 2.  Solitary spinal extradural plasmacytoma: a case report and literature review.

Authors:  S Tsutsumi; Y Yasumoto; M Ito
Journal:  Clin Neuroradiol       Date:  2012-06-16       Impact factor: 3.649

3.  Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy.

Authors:  Elisabeth G Vichaya; Xin Shelley Wang; Jessica A Boyette-Davis; Tito R Mendoza; Zijing He; Sheeba K Thomas; Nina Shah; Loretta A Williams; Charles S Cleeland; Patrick M Dougherty
Journal:  Cancer Chemother Pharmacol       Date:  2013-03-31       Impact factor: 3.333

4.  Clinical, electrophysiological and immunological study of peripheral nerves in Egyptian patients with monoclonal gammopathies.

Authors:  Mohamed M El-Difrawy; Nadia E Zaki; Hazem M Marouf; Mona W Ayad; Ahmed M Farag
Journal:  Int J Hematol       Date:  2011-12-17       Impact factor: 2.490

Review 5.  Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations.

Authors:  Bilal Mohty; Jean El-Cheikh; Ibrahim Yakoub-Agha; Philippe Moreau; Jean-Luc Harousseau; Mohamad Mohty
Journal:  Haematologica       Date:  2010-02       Impact factor: 9.941

6.  State-of-the-Art Management of Complications of Myeloma and Its Treatment.

Authors:  Monique A Hartley-Brown; Daniel M Sullivan; Rachid Baz
Journal:  Adv Hematol       Date:  2010-06-27

7.  Peripheral neuropathy associated with novel therapies in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board.

Authors:  Joseph D Tariman; Ginger Love; Emily McCullagh; Stacey Sandifer
Journal:  Clin J Oncol Nurs       Date:  2008-06       Impact factor: 1.027

8.  Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy.

Authors:  Paul G Richardson; Wanling Xie; Constantine Mitsiades; Asher A Chanan-Khan; Sagar Lonial; Hani Hassoun; David E Avigan; Anne Louise Oaklander; David J Kuter; Patrick Y Wen; Santosh Kesari; Hannah R Briemberg; Robert L Schlossman; Nikhil C Munshi; L Thompson Heffner; Deborah Doss; Dixie-Lee Esseltine; Edie Weller; Kenneth C Anderson; Anthony A Amato
Journal:  J Clin Oncol       Date:  2009-06-15       Impact factor: 44.544

9.  Effect of stem cell transplantation for B-cell malignancies on disease course of associated polyneuropathy.

Authors:  A C J Stork; W L van der Pol; D van Kessel; H M Lokhorst; N C Notermans
Journal:  J Neurol       Date:  2012-03-08       Impact factor: 4.849

10.  Restless legs syndrome in multiple myeloma patients.

Authors:  Ramazan Esen; Levent Ediz; Elif Gulcu; Fahrettin Demirdag; Ugur Turktas; Savas Guner; Senar Ebinc; Adem Cifci; Cengiz Demir
Journal:  J Clin Med Res       Date:  2012-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.